Consumer News Experimental Drug Helped Alzheimer S Patients In Small Trial

Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health and blood flow to the brain, researchers recently reported in the journal ... Read More

New trial finds diabetes drug and nasal insulin improve brain health in early Alzheimer's disease

A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes drug empagliflozin (Jardiance) and intranasal insulin, safely improve brain ... Read More

Alector’s dementia drug fails to slow patient decline in late-stage trial

An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage study, the company announced Tuesday. Read More

Alector shares plunge after dementia drug fails to slow disease progression

Alector said on Tuesday its experimental drug failed to slow the progression of a rare form of dementia in a late-stage trial, prompting the company to end the study and cut nearly half its workforce. Read More

Alector dementia drug, partnered with GSK, fails in key study

The negative readout led to a collapse in share price for Alector, which now plans to cut almost half of its workforce while refocusing and finding a new R&D leader. Read More

FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum. Read More

Roche Alzheimer's drug fails, joining long list of trial flops

An experimental Alzheimer's drug from Roche and AC Immune failed to slow cognitive and functional decline in a trial, the Swiss companies said on Wednesday, in a fresh setback to efforts to fight the ... Read More